Evidence for increased circulating procoagulant phospholipids in patients with COVID-19 pneumonia and their prognostic role

Clin Chem Lab Med. 2020 Oct 29;59(2):e53-e55. doi: 10.1515/cclm-2020-1260.
No abstract available

Keywords: COVID-19; microparticles; procoagulant phospholipids; thrombosis.

Publication types

  • Letter

MeSH terms

  • Anticoagulants / therapeutic use
  • Blood Coagulation / drug effects
  • Blood Coagulation Factors / analysis
  • C-Reactive Protein / analysis
  • COVID-19 / blood*
  • Disease Progression
  • Female
  • Ferritins / analysis
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Male
  • Middle Aged
  • Phospholipids / blood*
  • Prognosis
  • Prospective Studies
  • Pulmonary Embolism / prevention & control
  • SARS-CoV-2

Substances

  • Anticoagulants
  • Blood Coagulation Factors
  • Heparin, Low-Molecular-Weight
  • Phospholipids
  • C-Reactive Protein
  • Ferritins